Vivante Health, a digital health company that wants to bring virtual tools to digestive care raised $16 million in Series A funding led by 7wireVentures, Robert Garber, partner at 7wireVentures, tells Axios exclusively.
Why it matters: Digital health companies focused on heart and metabolic issues have seen sky-high fundraises and valuations in recent years, but far less attention has gone towards digitizing support for gastrointestinal (GI) conditions.
- “These conditions have been unfairly stigmatized,” says William Snyder, Vivante’s CEO. “And I think people are getting more secure in discussing different aspects of their health, such as behavioral health.”
- “Finally, someone’s paying attention to GI care,” says Garber.